open access

Vol 9, No 1 (2013)
Case report
Published online: 2013-04-02
Get Citation

Sequential systemic treatment for advanced colorectal cancer

Maja Habib, Piotr Potemski
Onkol. Prak. Klin 2013;9(1):33-36.

open access

Vol 9, No 1 (2013)
CASE REPORT
Published online: 2013-04-02

Abstract

Treatment of colorectal cancer is considered to be a major oncological problem. Colorectal cancer is the second
most common cause of cancer-related mortality in Europe and North America. Chemotherapy improves overall
survival in patients with metastatic colorectal cancer when compared to the best supportive care. The introduction
of irinotecan, oxaliplatin, and molecularly targeted agents has broadened the treatment options available
for patients with metastatic colorectal cancer and prolonged median survival to 20–24 months. A case of female
patients with relapse of metastatic colorectal cancer after 10 years of follow-up is presented.

Abstract

Treatment of colorectal cancer is considered to be a major oncological problem. Colorectal cancer is the second
most common cause of cancer-related mortality in Europe and North America. Chemotherapy improves overall
survival in patients with metastatic colorectal cancer when compared to the best supportive care. The introduction
of irinotecan, oxaliplatin, and molecularly targeted agents has broadened the treatment options available
for patients with metastatic colorectal cancer and prolonged median survival to 20–24 months. A case of female
patients with relapse of metastatic colorectal cancer after 10 years of follow-up is presented.
Get Citation

Keywords

colorectal cancer, cetuximab, EGFR inhibitors, targeted therapy, chemotherapy

About this article
Title

Sequential systemic treatment for advanced colorectal cancer

Journal

Oncology in Clinical Practice

Issue

Vol 9, No 1 (2013)

Article type

Case report

Pages

33-36

Published online

2013-04-02

Bibliographic record

Onkol. Prak. Klin 2013;9(1):33-36.

Keywords

colorectal cancer
cetuximab
EGFR inhibitors
targeted therapy
chemotherapy

Authors

Maja Habib
Piotr Potemski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl